3/18/2024 | BKHY | Fitch revises Elanco outlook to positive
|
2/5/2024 | BK | Market Commentary: Fitness International breaks; Elanco, Catalent loans rise; Waystar updated; GoodRx pulled
|
2/5/2024 | CLHY | Market Commentary: Fitness International breaks; Elanco, Catalent loans rise; Waystar updated; GoodRx pulled
|
2/5/2024 | BK | Elanco to pay down term loan B borrowings with asset sale proceeds
|
10/19/2023 | BKEMHY | Fitch eyes five issuers
|
7/10/2023 | HYLM | Elanco Animal Health to redeem notes due 2023 three weeks early
|
4/13/2023 | BKCVHY | Fitch drops Elanco
|
3/27/2023 | BK | Elanco Animal seeks amendment to shift term loan debt to SOFR
|
3/22/2023 | BKCVHY | Moody's downgrades Elanco
|
2/27/2023 | BKCVHY | S&P nips Elanco Animal Health
|
6/29/2022 | BK | Elanco get $175 million incremental term loan to pay down revolver
|
4/12/2022 | HYLM | Elanco gives early results, lifts tender cap in offer for 2023 notes
|
3/29/2022 | HYLM | Elanco Animal Health tenders for up to $250 million notes due 2023
|
10/12/2021 | SP | New Issue: RBC prices $100,000 capped barrier return enhanced notes on Elanco Animal Health
|
9/21/2021 | BKCVHYIG | Moody's lowers Elanco
|
8/12/2021 | BK | Elanco borrows $500 million incremental term loan for note repayment
|
8/9/2021 | BKBWCVHY | Elanco expects leverage ratio of 5.5x after acquisition, notes refi
|
7/29/2021 | SP | New Issue: JPMorgan prices $280,000 contingent interest autocalls on Elanco Animal Health
|
6/18/2021 | BKCVHY | Fitch revises Elanco view to negative
|
6/18/2021 | BKCVHY | Moody's eyes Elanco for trim
|
6/16/2021 | BK | Elanco plans new debt financing for Kindred Biosciences purchase
|
1/12/2021 | BKBWHY | Elanco on path to 3x leverage starting with $500 million debt paydown
|
12/22/2020 | SP | New Issue: TD Bank prices $1.64 million contingent interest barrier autocalls on Elanco
|
12/18/2020 | BKCVHY | Fitch trims Elanco
|
11/6/2020 | CV | Market Commentary: Cannabis convertibles trade higher with shares; Square surges; Elanco notes active
|
11/6/2020 | CV | Market Commentary: Morning Commentary: Cannabis convertibles trading higher; Square pops; Elanco busy
|
8/5/2020 | BKCVHY | S&P cuts Elanco unsecured notes, loans
|
7/30/2020 | BKCVHYIG | Fitch gives Elanco negative view
|
3/25/2020 | BK | Elanco provides covenant details on $5.03 billion of facilities
|
2/4/2020 | CLHY | Market Commentary: Elanco, Banijay, Aspen Dental, Innophos, Mister Car Wash, Dynatrace, Gigamon break
|
2/4/2020 | BK | Market Commentary: Elanco, Banijay, Aspen Dental, Innophos, Mister Car Wash, Dynatrace, Gigamon break
|
2/4/2020 | BK | Elanco lifts term B to $4.28 billion, flexes to Libor plus 175 bps
|
1/31/2020 | BK | Market Commentary: Cobham, viagogo, Jane, Pixelle, Wrench, Advisor, Golden Nugget, Veritext, Wells break
|
1/31/2020 | BKHY | Elanco ups term B to $3.7 billion, cancels other secured debt plans
|
1/28/2020 | BK | S&P cuts Bluestem
|
1/28/2020 | IG | Moody's upgrades Places for People
|
1/28/2020 | HY | Moody's downgrades Pyxus
|
1/28/2020 | CV | Moody’s shifts Givaudan view to negative
|
1/28/2020 | BKCVHYIG | S&P rates Elanco loans, notes BB+
|
1/27/2020 | CLHY | Market Commentary: Elanco, Gardner Denver detail loan offers, funds sustain $238 million Friday outflows
|
1/27/2020 | BK | Market Commentary: Elanco, Gardner Denver detail loan offers, funds sustain $238 million Friday outflows
|
1/27/2020 | BK | Elanco sets talk in $2.43 billion term loan; commitments due Feb. 6
|
1/27/2020 | BKHYIG | Fitch to rate Elanco loan, notes BBB-
|
1/27/2020 | BKHYIG | Moody’s cuts Elanco, rates facilities, notes Baa3
|
1/24/2020 | CV | Market Commentary: Atlassian convertibles eyed post-earnings; Elanco gains continue; Luckin Coffee drops
|
1/24/2020 | CV | Market Commentary: Morning Commentary: Atlassian convertibles eyed post-earnings; Elanco gains continue
|
1/23/2020 | BK | Elanco sets Monday bank meeting for $5.1 billion of bank debt
|
1/23/2020 | CV | Market Commentary: Barclays synthetic on deck; BofA downsizes; Elanco equity units expand; Teradyne active
|
1/23/2020 | CV | Market Commentary: Morning Commentary: Elanco Animal Health equity units hit aftermarket; BofA downsizes
|
1/23/2020 | CV | New Issue: Elanco Animal Health prices $550 million three-year equity units to yield 5%, up 20%
|
1/22/2020 | CV | Market Commentary: Barclays synthetic on tap; BofA synthetic tied to Charter, Elanco equity units eyed
|
1/22/2020 | CV | Market Commentary: Morning Commentary: BofA synthetic tied to Charter on tap; Elanco equity units eyed
|
1/21/2020 | CV | Market Commentary: Charter synthetic on tap; Luckin Coffee, China-based convertibles come in; Tesla active
|
1/21/2020 | CV | Elanco Animal Health talks $550 million three-year tangible equity units with 5% yield, up 20%
|
12/23/2019 | BK | Elanco Animal Health amends terms of revolving, term loan agreements
|
9/11/2019 | BKBWHYIG | Elanco Animal Health aims to de-lever to 3x from 5x by year-end 2022
|
8/21/2019 | BKCVDDEMIGPV | Market Commentary: Elanco varies after animal health buyout news; oil names trend positive; PG&E rises
|
8/21/2019 | HY | Market Commentary: Elanco varies after animal health buyout news; oil names trend positive; PG&E rises
|
8/21/2019 | HY | Market Commentary: Morning Commentary: Oil price improvement boosts junk energy names; E&Ps see gains
|
8/20/2019 | HY | Market Commentary: PG&E continues to decline; Endo gains after settling suit; Tenet varies
|
8/20/2019 | BKHYIG | Moody’s puts Elanco on review
|
8/20/2019 | BKHYIG | S&P places Elanco on negative watch
|
8/20/2019 | BKHYIG | Fitch places Elanco Animal Health on watch
|
8/20/2019 | BKHYIG | Elanco gets $6.5 billion debt commitment for purchase of Bayer’s animal health business
|
12/18/2018 | BWHYIG | Elanco Animal Health to reduce debt in bid to become investment-grade
|
8/14/2018 | EMHYPFPV | Market Commentary: AstraZeneca, Elanco, Roper, Apache, AerCap price; United Technologies firms
|
8/14/2018 | IG | Market Commentary: AstraZeneca, Elanco, Roper, Apache, AerCap price; United Technologies, McDonald’s firm
|
8/14/2018 | HYIG | New Issue: Elanco Animal Health sells $2 billion of senior notes in three parts
|
8/14/2018 | IG | Market Commentary: Morning Commentary: Strong supply on tap; AstraZeneca, Apache, Roper, IBRD eye deals
|
8/13/2018 | EMHYPFPV | Market Commentary: United Technologies sells $11 billion; McDonald’s, Zoetis tap primary; Apache eyed
|
8/13/2018 | IG | Market Commentary: United Technologies sells $11 billion; McDonald’s, Zoetis tap primary market; Apache eyed
|
8/13/2018 | IG | Market Commentary: Morning Commentary: United Technologies, Zoetis, Black Hills market notes; Apache eyed
|
8/10/2018 | EMHYPFPV | Market Commentary: United Technologies continues calls; supply weighs; spreads widen; bonds mixed
|
8/10/2018 | IG | Market Commentary: United Technologies continues calls; supply weighs; credit spreads widen; bonds mixed
|
8/10/2018 | IG | Market Commentary: Morning Commentary: United Technologies continues calls; supply weighs; inflows up
|
8/9/2018 | IG | Market Commentary: Lloyds, Welltower, CNH, Charter price; United Technologies, Elanco hold calls
|
8/9/2018 | EMHYPFPV | Market Commentary: Lloyds, Welltower, CNH, Charter price; United Technologies, Elanco hold calls
|
8/9/2018 | IG | Market Commentary: Morning Commentary: Lloyds, Welltower, CNH on deck; Elanco holds calls; new issues firm
|
8/8/2018 | IG | Market Commentary: Starbucks, Regions, Entergy, Fidelity, National Fuel price; Elanco eyes $2.5 billion deal
|
8/8/2018 | EMHYPFPV | Market Commentary: Starbucks, Regions, Entergy, Fidelity, National Fuel price; Elanco eyes $2.5 billion deal
|
8/8/2018 | HYIG | Elanco Animal Health sets fixed-income investor calls for possible $2.5 billion bond offering
|
8/8/2018 | BKHYIG | S&P gives Elanco, debt BB+
|
8/8/2018 | BKHYIG | Fitch assigns BB+ to Elanco
|
8/8/2018 | BKHYIG | Moody’s rates Elanco debt Baa3
|